OBJECTIVES: South African HIV care providers are exploring ways to reduce the intensity of patient visits while maintaining high quality of care. We used routinely collected data to model whether a simple screening tool could identify stable patients who would not need to see a doctor during a scheduled medical visit. DESIGN: We identified stable and nonstable visits from January 2007 to September 2011 at a large HIV clinic in Johannesburg, SA. Stable medical visits were defined as having all of the following: stable CD4 count, undetectable viral load, stable weight, not pregnant, no comorbidity, no regimen change within three months, and normal laboratory results for hemoglobin, alanine aminotransferase, and creatinine clearance. METHODS: We assessed the sensitivity and specificity of nonstable visits at predicting indicators of disease progression or needing additional care: (1) ART regimen change and (2) follow-up visits in <2 and <4 weeks from previous visit. RESULTS: Stable visits had a sensitivity of 88.9% (95% confidence interval: 88.2 to 89.7) and a specificity of 44.8% (44.5 to 44.1) at predicting ART therapy changes, and a sensitivity of 72.6% (71.8 to 73.4) and specificity of 45.1% (44.8 to 45.4) for predicting a follow-up visit interval of <2 weeks and similar results for predicting a follow-up visit interval of <4 weeks. CONCLUSIONS: Our retrospective analysis suggests an approach to potentially reduce the number of medical visits while missing few visits in which changes in regimen or additional care would be needed. Evaluation of our criteria in a primary care setting is needed to determine whether they could safely reduce visits.
OBJECTIVES: South African HIV care providers are exploring ways to reduce the intensity of patient visits while maintaining high quality of care. We used routinely collected data to model whether a simple screening tool could identify stable patients who would not need to see a doctor during a scheduled medical visit. DESIGN: We identified stable and nonstable visits from January 2007 to September 2011 at a large HIV clinic in Johannesburg, SA. Stable medical visits were defined as having all of the following: stable CD4 count, undetectable viral load, stable weight, not pregnant, no comorbidity, no regimen change within three months, and normal laboratory results for hemoglobin, alanine aminotransferase, and creatinine clearance. METHODS: We assessed the sensitivity and specificity of nonstable visits at predicting indicators of disease progression or needing additional care: (1) ART regimen change and (2) follow-up visits in <2 and <4 weeks from previous visit. RESULTS: Stable visits had a sensitivity of 88.9% (95% confidence interval: 88.2 to 89.7) and a specificity of 44.8% (44.5 to 44.1) at predicting ART therapy changes, and a sensitivity of 72.6% (71.8 to 73.4) and specificity of 45.1% (44.8 to 45.4) for predicting a follow-up visit interval of <2 weeks and similar results for predicting a follow-up visit interval of <4 weeks. CONCLUSIONS: Our retrospective analysis suggests an approach to potentially reduce the number of medical visits while missing few visits in which changes in regimen or additional care would be needed. Evaluation of our criteria in a primary care setting is needed to determine whether they could safely reduce visits.
Authors: Christopher J Colvin; Lara Fairall; Simon Lewin; Daniella Georgeu; Merrick Zwarenstein; Max O Bachmann; Kerry E Uebel; Eric D Bateman Journal: S Afr Med J Date: 2010-03-30
Authors: Matthew P Fox; Mhairi Maskew; A Patrick MacPhail; Lawrence Long; Alana T Brennan; Daniel Westreich; William B MacLeod; Pappie Majuba; Ian M Sanne Journal: Int J Epidemiol Date: 2012-03-20 Impact factor: 7.196
Authors: Ian Sanne; Catherine Orrell; Matthew P Fox; Francesca Conradie; Prudence Ive; Jennifer Zeinecker; Morna Cornell; Christie Heiberg; Charlotte Ingram; Ravindre Panchia; Mohammed Rassool; René Gonin; Wendy Stevens; Handré Truter; Marjorie Dehlinger; Charles van der Horst; James McIntyre; Robin Wood Journal: Lancet Date: 2010-07-03 Impact factor: 79.321
Authors: Lawrence Long; Alana Brennan; Matthew P Fox; Buyiswa Ndibongo; Imogen Jaffray; Ian Sanne; Sydney Rosen Journal: PLoS Med Date: 2011-07-19 Impact factor: 11.069
Authors: William B MacLeod; Jacob Bor; Sue Candy; Mhairi Maskew; Matthew P Fox; Katia Bulekova; Alana T Brennan; James Potter; Cornelius Nattey; Dorina Onoya; Koleka Mlisana; Wendy Stevens; Sergio Carmona Journal: BMJ Open Date: 2022-10-19 Impact factor: 3.006
Authors: Colette Guiteau Moise; Vanessa R Rivera; Kelly A Hennessey; Clovy Bellot; Chris Nicholas; Anna P Fang; Rose Irène Verdier; Patrice Severe; Alix Sainvil; Benedict Charles; Derothy Dorval; Juseline St Amour; Jean W Pape; Serena P Koenig Journal: J Acquir Immune Defic Syndr Date: 2018-09-01 Impact factor: 3.731